A dosimetric approach to patient-specific radioiodine treatment of Graves' disease with incorporation of treatment-induced changes in thyroid mass

Medical Physics

Volumn 31, Issue 7, 2004, Pages 2121-2127

  Traino, A Claudio ^a   Di Martino, Fabio ^a   Lazzeri, Mauro ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSIS; DISEASE CONTROL;

ABSORBED DOSE; MASS REDUCTION; PATIENT SPECIFIC; RADIOIODINE; RADIOIODINE THERAPY; RADIOIODINE TREATMENT; RADIONUCLIDE THERAPY; TARGET ORGANS;

PATIENT TREATMENT;

IODINE 131; RADIOACTIVE IODINE; RADIOISOTOPE;

ALGORITHM; ARTICLE; DOSIMETRY; DRUG CLEARANCE; GRAVES DISEASE; MATHEMATICAL MODEL; PRIORITY JOURNAL; RADIATION ABSORPTION; RADIATION DOSE; RADIOISOTOPE THERAPY; THYROID TUMOR; VALIDATION PROCESS;

EID: 3142695423     PISSN: 00942405     EISSN: None     Source Type: Journal    
DOI: 10.1118/1.1763411     Document Type: Article

References (10)

1. S. R. Thomas, "Options for radionuclide therapy: from fixed activity to patient-specific treatment planning," Radiopharm. 17, 71-82 (2002).
2. H. Peters, C. Fisher, U. Bogner, and H. Schleusener, "Radioiodine therapy of Graves' hyperthyroidism: standard vs. Calculated 131-I activity. Results from a prospective, randomised, multicentre study," Eur. J. Clin. Invest. 25, 186-193 (1995).
3. L. D. Marinelli, E. H. Quimby, and G. J. Hine, "Dosage determination with radioactive isotopes. II Practical considerations in therapy and protection," Am. J. Roentgenol. 59, 260-281 (1948).
4. M. G. Stabin, "MIRDOSE the personal computer software for use in internal dose assessment in nuclear medicine," J. Nucl. Med. 37, 538-546 (1996).
5. M. G. Stabin, "Internal radiation dosimetry," in Nuclear Medicine Vol. 1, edited by R. E. Henkin et al. (Mosby, St. Louis, 1996), pp. 316-333.
6. Y. Muratami, J. Takamatsu, S. Sakane, K. Kuma, and N. Ohsawa, "Changes in thyroid volume in response to radioactive iodine for Graves' hyperthyroidism correlated with activity of thyroid stimulating antibody and treatment outcome," J. Clin. Endocrinol. Metab. 81, 3257-3260 (1996).
7. B. Nygaard, L. Hegedüs, M. Gervil, H. Hjalgrim, B. M. Hansen, P. Söe Jensen, and J. M. Hansen, "Influence of compensated radioiodine therapy on thyroid volume and incidence of hypothyroidism in Graves' disease," J. Int. Med. 238, 491-497 (1995).
8. H. Peters, C. Fisher, U. Bogner, C. Reiners, and H. Schleusener, "Reduction in thyroid volume after radioiodine therapy of Graves' hyperthyroidism: results from a prospective, randomized, multicentre study," Eur. J. Clin. Invest. 26, 59-63 (1996).
9. A. Szebeni and E. Beleznay, "New simple method for thyroid volume determination by ultrasonography," J. Clin. Ultrasound 20, 329-337 (1992).
10. F. Di Martino, A. C. Traino, A. B. Brill, M. G. Stabin, and M. Lazzeri, "A theoretical model for prescription of the patient-specific therapeutic activity for radioiodine therapy of Graves' disease," Phys. Med. Biol. 47, 1493-1499 (2002).